Concinnity Genetics Garners £3m Seed Funding Led by Eos Advisory
Deal News | Dec 16, 2024 | EOS Investment Management Limited (Eos Advisory)
Concinnity Genetics has successfully closed a £3m seed funding round, which was led by Eos Advisory and was oversubscribed. The funding round also saw participation from Scottish Enterprise, Maven Capital Partners, and Old College Capital, the University of Edinburgh's venture investment fund. Concinnity, founded by Jessica Birt and Matthew Dale, seeks to advance gene therapies through innovative control mechanisms leveraging synthetic biology and artificial intelligence. This funding will support Concinnity's operational growth in Scotland's life science hub, enabling them to launch new programmes and solidify partnerships. The support from Scottish Enterprise has been pivotal, showcasing the importance of life sciences to Scotland's economy. The technology developed by Concinnity has been heralded as a potential game-changer in gene therapies.
Sectors
- Biotechnology
- Investment
- Artificial Intelligence
Geography
- United Kingdom – Concinnity Genetics operates out of Scotland and the UKRI Centre for Mammalian Synthetic Biology is based in the UK.
Industry
- Biotechnology – Concinnity Genetics is involved in developing synthetic biology technologies for gene therapies, which places it firmly within the biotechnology industry.
- Investment – The article discusses a seed funding round involving several investment entities, making the investment sector relevant.
- Artificial Intelligence – Concinnity Genetics uses AI to enhance their gene therapy solutions, connecting it to the AI industry.
Financials
- £3m – Total amount raised in the seed funding round led by Eos Advisory for Concinnity Genetics.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Concinnity Genetics | Target Company | Company | A company focused on developing advanced gene control systems using synthetic biology and AI. |
| Eos Advisory | Lead Investor | Company | A private equity firm that led the seed funding round for Concinnity Genetics. |
| Scottish Enterprise | Investor | Government | A government agency that supports economic development in Scotland and participated in funding. |
| Maven Capital Partners | Investor | Company | An investment firm participating in the seed round for Concinnity Genetics. |
| Old College Capital | Investor | Company | The University of Edinburgh's in-house venture investment fund involved in the investment. |
| Jessica Birt | Co-founder | Person | One of the co-founders and the chief executive of Concinnity Genetics. |
| Matthew Dale | Co-founder | Person | Co-founder of Concinnity Genetics. |
| Susan Rosser | Professor | Person | Professor at the UKRI UK Centre for Mammalian Synthetic Biology, where Concinnity was spun out. |
| Andrew McNeill | Managing Partner | Person | Managing partner at Eos Advisory, the firm leading the investment. |
| Andrea Taylor | Chief Executive | Person | CEO of Edinburgh Innovations, involved in supporting the commercialization efforts. |